ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First Swap – Seeking Alpha

Core Biotech Buys #17: Positive Commentary For Gene Therapy And Our First SwapSeeking AlphaFDA Commissioner Scott Gottlieb´s remarks concerning the potential of gene therapy, bode well for stocks participating in that theme. A clinical hold for CRISPR … Continue reading

2018-05-31 Michael Zand NEWS

Three CRISPR Scientists Win Prestigious Award, Fanning Controversy Over Credit – Scientific American

Continue reading

2018-05-31 Michael Zand NEWS

Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial – Breast Cancer News

Breast Cancer NewsPotential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in TrialBreast Cancer NewsBria-IMT, also called SV-BR-1-GM, is a potential immunotherapy made of a breast tumor cell line engineered to re… Continue reading

2018-05-31 Michael Zand NEWS

Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial – Breast Cancer News

Breast Cancer NewsPotential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in TrialBreast Cancer NewsBria-IMT, also called SV-BR-1-GM, is a potential immunotherapy made of a breast tumor cell line engineered to re… Continue reading

2018-05-31 Michael Zand NEWS

Recon: FDA Puts CRISPR Trial on Hold – Regulatory Focus

Regulatory FocusRecon: FDA Puts CRISPR Trial on HoldRegulatory FocusGene-Therapy Company Crispr Drops as FDA Puts Trial on Hold (Bloomberg-$) (Xconomy) (Boston Business Journal-$) (Endpoints) (BioPharma Dive); Minnesota sues opioid maker Insys over imp… Continue reading

2018-05-31 Michael Zand NEWS

Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia – Drug Discovery & Development


Scientific American

Three CRISPR Scientists Win Prestigious Award, Fanning Controversy Over Credit
Scientific American
One of the world’s richest science awards, given only in alternate years, will go to three discoverers of the CRISPR-Cas9 genome-editing tool, the Norwegian Academy of Science and Letters announced on Thursday. Emmanuelle Charpentier of the Max …
CRISPR Gene Editing Pioneers Win Kavli Prize for NanoscienceQuanta Magazine
Kavli Prize to CRISPR ResearchersGenomeWeb
Broad’s Feng Zheng snubbed in science awards to CRISPR/Cas9 discoverersSeeking Alpha
Laboratory Equipment –GeekWire –UC Berkeley
all 12 news articles »
Continue reading

2018-05-31 Michael Zand NEWS

Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind – MIT Technology Review


Drug Discovery & Development

Approach Could Limit Toxicity of CAR T Therapy in Acute Myeloid Leukemia
Drug Discovery & Development
A new approach pioneered at the University of Pennsylvania’s Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a specific protein – CD33 – that’s …

Continue reading

2018-05-31 Michael Zand NEWS

Penn-developed Approach Could Limit Toxicity of CAR T Cell Therapy in Acute Myeloid Leukemia – Newswise (press release)


MIT Technology Review

Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind
MIT Technology Review
But as AveXis and other biotech companies race to bring transformative gene therapies to market, states have been slow to adopt screening tests for genetic diseases that are, increasingly, treatable. Newborn screening tests in the US cover a minimum of …

and more »

Continue reading

2018-05-31 Michael Zand NEWS
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Penn-developed Approach Could Limit Toxicity of CAR T Cell Therapy in Acute Myeloid Leukemia
Newswise (press release)
Newswise — PHILADELPHIA – A new approach pioneered at the University of Pennsylvania’s Abramson Cancer Center may provide a new path towards treating Acute Myeloid Leukemia (AML) with CAR T cells. To treat AML, investigators have to target a …